News

September 16, 2025

Development of a cyst-targeted therapy for polycystic kidney disease using an antagonistic dimeric IgA monoclonal antibody against cMET

Margaret F Schimmel 1, Bryan C Bourgeois 1, Alison K Spindt 1, Sage A Patel 1, Tiffany Chin 1, Gavin E Cornick 1, Yuqi Liu 1, Thomas Weimbs 2

DOI: 10.1016/j.xcrm.2025.102335

 

Abstract

Related Links

September 04, 2025

Degrees of Health Podcast

'High-protein diets hurt your kidneys!'. 'Once kidney disease starts, it only gets worse'. Heard something similar? It's just not the whole picture and also showing to be quite far from the truth.

Related Links

August 25, 2025

Colgan, D. D.; Stadler, D. D.; Hope, A. A.; Zwickey, H.; Davenport, T. E.; Weimbs, T. Clinically Meaningful Improvements in Long COVID Symptoms Following Ketogenic Metabolic Therapy Combined with Lifestyle Interventions - A Clinical Case Report and Review of the Literature. CRCM 2025, 14 (08), 391–410.

Abstract:

Related Links

July 01, 2025

Congratulations to Melina Messing, PhD for receiving the 2025 Jared J. Grantham Research Fellowship Award to support her research in the Weimbs laboratory. Melina will study "Immune Mechanisms Underlying Efficacy of Ketogenic Metabolic Therapy in Polycystic Kidney Disease".

 

 

Related Links

June 06, 2025

Athinarayanan, S. J.; Roberts, C. G. P.; Phinney, S. D.; Weimbs, T.; Friedman, A. N.; Volek, J. S. Effects of a Continuous Remote Care Intervention Including Nutritional Ketosis on Kidney Function and Inflammation in Adults with Type 2 Diabetes: A Post-Hoc Latent Class Trajectory Analysis. Front. Nutr. 2025, 12. https://doi.org/10.3389/fnut.2025.1609737.

Related Links

May 10, 2025

Congratulations to Weimbs Lab undergraduate researcher Emily Ngo who has been accepted to the University of California Leadership Excellence through Advanced Degrees (UC LEADS) program for the 2025-27 Scholar Cohort

October 31, 2024

Messing, Melina, Jacob A. Torres, Nickolas Holznecht, and Thomas Weimbs. “Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.” Nutrients 16, no. 19 (January 2024): 3281.

https://doi.org/10.3390/nu16193281

 

Related Links

September 27, 2024

Congratulations to all authors!

Torres, J. A.; Holznecht, N.; Asplund, D. A.; Kroes, B. C.; Amarlkhagva, T.; Haeffner, M. M.; Sharpe, E. H.; Koestner, S.; Strubl, S.; Schimmel, M. F.; Kruger, S.; Agrawal, S.; Aceves, B. A.; Thangaraju, M.; Weimbs, T. β-Hydroxybutyrate Recapitulates the Beneficial Effects of Ketogenic Metabolic Therapy in Polycystic Kidney Disease. iScience 2024, 27 (9). https://doi.org/10.1016/j.isci.2024.110773.

Related Links

Pages